
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4.2021 | 28.5274949084 | 14.73 | 18.9321 | 14.71 | 1375437 | 16.41882607 | CS |
4 | -1.4979 | -7.33186490455 | 20.43 | 20.66 | 12.9 | 1862870 | 15.73484591 | CS |
12 | -2.2579 | -10.6554978764 | 21.19 | 25.29 | 12.9 | 1816686 | 19.32478259 | CS |
26 | 0.7421 | 4.07971412864 | 18.19 | 25.29 | 12.9 | 1536177 | 18.91382099 | CS |
52 | 13.7021 | 261.990439771 | 5.23 | 25.29 | 5.12 | 1498462 | 15.0183225 | CS |
156 | -8.5079 | -31.0054664723 | 27.44 | 29.14 | 5.12 | 1304317 | 15.19390404 | CS |
260 | -6.2179 | -24.7232604374 | 25.15 | 33.0899 | 5.12 | 1123176 | 16.86290719 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.